First Time Loading...

Medmix Ltd
SIX:MEDX

Watchlist Manager
Medmix Ltd Logo
Medmix Ltd
SIX:MEDX
Watchlist
Price: 15.14 CHF 0.26%
Updated: May 2, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

474.6m
-0.5%
Revenue
Jun 30, 2023 474.6m
Dec 31, 2022 477.1m
Jun 30, 2022 479.6m
Dec 31, 2021 457.3m
23.1m
-47%
Operating Income
Jun 30, 2023 23.1m
Dec 31, 2022 43.5m
Jun 30, 2022 64.5m
Dec 31, 2021 62.8m
-4.9m
Net Income
Jun 30, 2023 -4.9m
Dec 31, 2022 11.6m
Jun 30, 2022 30.5m
Dec 31, 2021 44m

Earnings Waterfall
Medmix Ltd

Revenue
474.6m CHF
Cost of Revenue
-315.1m CHF
Gross Profit
159.5m CHF
Operating Expenses
-136.4m CHF
Operating Income
23.1m CHF
Other Expenses
-28m CHF
Net Income
-4.9m CHF

Income Statement
Medmix Ltd

Rotate your device to view
Income Statement
Currency: CHF
Dec-2021 Jun-2022 Dec-2022 Jun-2023
Revenue
Revenue
457
N/A
480
+5%
477
-1%
475
-1%
Gross Profit
Cost of Revenue
(276)
(291)
(302)
(315)
Gross Profit
181
N/A
189
+4%
175
-7%
160
-9%
Operating Income
Operating Expenses
(118)
(124)
(132)
(136)
Selling, General & Administrative
(96)
(101)
(109)
(113)
Research & Development
(23)
(23)
(24)
(24)
Other Operating Expenses
0
0
1
1
Operating Income
63
N/A
65
+3%
44
-33%
23
-47%
Pre-Tax Income
Interest Income Expense
(10)
(11)
(10)
(10)
Non-Reccuring Items
(1)
(16)
(21)
(19)
Total Other Income
(0)
0
0
(1)
Pre-Tax Income
51
N/A
38
-27%
12
-68%
(7)
N/A
Net Income
Tax Provision
(7)
(7)
(1)
2
Income from Continuing Operations
44
30
12
(5)
Net Income (Common)
44
N/A
31
-31%
12
-62%
(5)
N/A
EPS (Diluted)
1.07
N/A
0.72
-33%
0.28
-61%
-0.12
N/A

See Also

Summary
MEDX intrinsic value, competitors valuation, and company profile.
DCF Valuation
MEDX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MEDX stock valuation using valuation multiples.
Wall Street Estimates
MEDX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MEDX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.